Cabozantinib Interactions
There are 531 drugs known to interact with cabozantinib, along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 322 are major, 206 are moderate, and 3 are minor.
- View all 531 medications that may interact with cabozantinib
- View cabozantinib alcohol/food interactions (2)
- View cabozantinib disease interactions (8)
Most frequently checked interactions
View interaction reports for cabozantinib and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- Anoro Ellipta (umeclidinium / vilanterol)
- Aspirin Low Strength (aspirin)
- Claritin (loratadine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- CoQ10 (ubiquinone)
- Eliquis (apixaban)
- Entyvio (vedolizumab)
- Glycerol (glycerin)
- High Potency B Complex with B12 and C (multivitamin)
- Imodium (loperamide)
- Iron Sulfate (ferrous sulfate)
- Keppra (levetiracetam)
- Lenvima (lenvatinib)
- Lexapro (escitalopram)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Opdivo (nivolumab)
- Paracetamol (acetaminophen)
- Pepcid AC (famotidine)
- Quercetin (bioflavonoids)
- Synthroid (levothyroxine)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
- Xanax (alprazolam)
Cabozantinib alcohol/food interactions
There are 2 alcohol/food interactions with cabozantinib.
Cabozantinib disease interactions
There are 8 disease interactions with cabozantinib which include:
- hemorrhagic events
- GI perforation
- hepatic impairment
- hypertension
- renal impairment
- RPL syndrome
- thromboembolism
- lung toxicity
Report options
More about cabozantinib
- cabozantinib consumer information
- Compare alternatives
- Reviews (28)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Lutathera
Lutathera is a targeted radiotherapy used for gastroenteropancreatic neuroendocrine tumors ...
Armour Thyroid
Armour Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
NP Thyroid
NP Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid cancer ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
